Skip to main content
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit
STEM
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
Sections
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit
STEM

Chemist Develops Potential Drug to Treat Type 2 Diabetes Without Harsh Side Effects

Sunday, July 12, 2020, By Dan Bernardi
Share
BioInspiredCollege of Arts and SciencesfacultyresearchSTEM
head shot

Robert P. Doyle

Robert P. Doyle, the Laura J. and L. Douglas Meredith Professor in the Department of Chemistry in the College of Arts and Sciences and adjunct associate professor of medicine at SUNY Upstate Medical University, has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects of nausea, vomiting and, in select cases, undesired weight loss. His research article, “Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis,” has been published in the prestigious journal Cell Reports.

A common group of drugs used to treat type 2 diabetes are glucagon-like peptide-1 receptor (GLP-1R) agonists. While they do lower blood sugar levels in diabetic patients, their side effects include nausea, vomiting and weight loss.

Through a grant from the National Institutes of Health (NIH), Doyle and his team found a way to combine two molecules into a new substance that so far seems to lower blood sugar without those undesired side effects.

In technical terms, the team developed a new area of bioconjugation—a chemical technique used to couple two molecules. By binding together exendin-4 (Ex4), an FDA-approved GLP-1R agonist, to dicyanocobinamide (Cbi), which is a small piece of the complex vitamin B12 molecule, they produced Cbi-Ex4 in a technique they call “corrination.”

Data collected from testing Cbi-Ex4 in the musk shrew (Suncus murinus), the mammal used in this study due to its ability to vomit (rodents and many mammals lack that ability), revealed beneficial effects as evidenced by improved blood sugar levels during glucose tolerance tests and a profound reduction in vomiting compared to Ex4. Importantly, no weight loss was noted, again in stark contrast to the currently approved GLP-1R agonist, making this new drug ideal for patients who require glucoregulation without affecting their body mass index (BMI) levels. This drug could therefore benefit diabetes patients who also live with cystic fibrosis, COPD, sarcopenia, cancer or HIV, where weight-loss is counter-indicated.

The next step in the development of this groundbreaking drug is to move it through the pre-clinical phase into phase I human studies. Doyle and his team have submitted a new grant proposal to the NIH to fund this effort.

Doyle’s research was conducted in collaboration with the labs of Matt Hayes, professor in the Department of Psychiatry, University of Pennsylvania, and Bart C. De Jonghe, professor in the Department of Biobehavioral Health Sciences, University of Pennsylvania.

  • Author

Dan Bernardi

  • Recent
  • Funding Expands for Newhouse Professors’ Work on Technology to Combat Fake News
    Wednesday, May 18, 2022, By Wendy S. Loughlin
  • Biology and Earth and Environmental Sciences Departments Come Together on Diversity and Engagement Initiatives
    Tuesday, May 17, 2022, By News Staff
  • As the School of Education’s Italy Program Returns, Sara Jo Soldovieri ’18, G’19 Reflects on Its Influence
    Tuesday, May 17, 2022, By Martin Walls
  • Center for Fellowship and Scholarship Advising Team Helps Match Students With Unique Experiences That Enhance Their Studies
    Tuesday, May 17, 2022, By Jen Maser
  • COVID-19 Update: Public Health Protocols for Summer 2022
    Tuesday, May 17, 2022, By News Staff

More In STEM

Biology and Earth and Environmental Sciences Departments Come Together on Diversity and Engagement Initiatives

In 1948, Professor James Hope Birnie became Syracuse University’s first African American faculty member in biology, teaching here until 1951. He was also one of its first biology faculty members to be supported by the National Institutes of Health (NIH)….

Black Hole Image Shows Einstein Was Right, Once Again

Today a team of astronomers announced they successfully captured the first direct image of the black hole at the center of the Milky Way galaxy. Duncan Brown is the Charles Brightman Endowed Professor of Physics at Syracuse University’s College of…

Biomedical and Chemical Engineering Professor’s Research Team Receives Multiple Awards at Society for Biomaterials Conference

Biomedical and chemical engineering Professor Mary Beth Monroe attended the Society for Biomaterials (SFB) 2022 meeting in Baltimore, Maryland, with Ph.D. students Anand Vakil, Henry Beaman, Changling Du and Maryam Ramezani, master’s student Natalie Petryk ’21, G’22 and undergraduate students Caitlyn…

Viewing a Microcosm Through a Physics Lens

“What can physics offer biology?” This was how Alison Patteson, assistant professor in the College of Arts and Sciences’ physics department and a faculty member in the BioInspired Institute, began the explanation of why her physics lab was studying bacteria. In…

University’s Top Putnam Math Competition Finisher Awarded Inaugural Erdős Prize

Junior Connor Ritchie has won the Department of Mathematics’ inaugural Erdős Prize for being Syracuse University’s top finisher in the William Lowell Putnam Mathematical Competition. The Putnam contest is the preeminent mathematics competition for undergraduate college students in the United States and Canada,…

Subscribe to SU Today

If you need help with your subscription, contact sunews@syr.edu.

Connect With Us

  • Twitter
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
Social Media Directory

For the Media

Find an Expert Follow @SyracuseUNews
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • @SyracuseU
  • @SyracuseUNews
  • @SUCampus
  • Social Media Directory
  • Accessibility
  • Privacy
  • Campus Status
  • Syracuse.edu
© 2022 Syracuse University News. All Rights Reserved.